What Causes Knee Joint Wear?
Cartilage covers the ends of the bones in the knee, cushioning them for smooth, pain-free movement. When it wears — sometimes in localised areas — it can cause discomfort on weight-bearing or when climbing stairs, limiting mobility. Because cartilage heals poorly, options that support the joint are of interest.
How the ChondroFiller Injection Works
ChondroFiller is a Class III CE-marked, cell-free collagen gel made from Type I collagen — it needs no cell harvesting. Given as a non-surgical, ultrasound-guided injection into the knee, it may settle over worn surfaces, adding a protective, cushioning layer that helps reduce grinding. Its gel can absorb load and adapt to the forces inside a joint. It is collagen-based with biological potential, but it is best understood as a supportive, joint-preserving injection — not a cure or reversal of arthritis. The CE marking and published outcome data belong to ChondroFiller as a medical device.
Could It Suit You?
ChondroFiller may suit people with osteoarthritis or localised knee joint wear — for example, knee clicking or pain on stairs — who want a non-surgical option. It is not a guaranteed cure; results vary. Encouraging experience comes from joints such as the knee, ankle and thumb base, but responses differ between people.
The ChondroFiller Injection and Liquid Cartilage: Two Distinct Pathways
It is worth clarifying that the ChondroFiller injection and Liquid Cartilage are not the same thing. The ChondroFiller injection is a non-surgical, outpatient procedure — no theatre, no anaesthetic, no incision. Liquid Cartilage is a separate, surgical protocol developed by Professor Lee: a keyhole (arthroscopic) procedure that delivers the ChondroFiller scaffold together with biological adjuncts and, where indicated, the patient's own stem cells. Liquid Cartilage is used for larger or more complex defects requiring genuine surgery. Whether you need the injection pathway or the surgical pathway depends on your diagnosis, the size and location of any cartilage lesion, and your clinical assessment.
Taking the Next Step
If you have knee pain or suspect joint wear, a thorough assessment with a qualified professional is the best first step. Ask about your diagnosis, whether the ChondroFiller injection may suit you, and the likely benefits and risks. At the London Cartilage Clinic, Professor Paul Lee provides balanced, realistic advice and can determine whether a non-surgical injection or a different pathway is appropriate for your situation.
Conclusion
The ChondroFiller injection is a non-surgical option that may help support a worn knee and ease symptoms for some people. It is not a cure. For personalised advice, always consult a qualified professional.
References
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- The ChondroFiller injection is a non-surgical, outpatient procedure — the CE-marked collagen gel is delivered by ultrasound-guided injection, with no theatre or anaesthetic. Liquid Cartilage is Professor Lee's keyhole surgical protocol, which delivers ChondroFiller alongside biological adjuncts and, where indicated, the patient's own stem cells. They are distinct pathways suited to different clinical situations.
- The injection is performed under ultrasound guidance as an outpatient procedure. Discomfort is generally mild and comparable to other joint injections. Your clinician can discuss what to expect at assessment.
- It is a non-surgical collagen injection that may add a protective, cushioning layer over worn joint surfaces to help reduce grinding. It is not a cure, and results vary between individuals.
- People with osteoarthritis or localised knee joint wear who want a non-surgical option and have realistic expectations. A clinical assessment is needed to confirm suitability — not everyone with knee pain will be appropriate for this injection.
- Evidence from published studies suggests benefits can persist over 12 to 36 months in suitable patients, but individual responses vary. Your clinician can discuss what the evidence suggests for your specific situation.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
